Thought Leaders in Healthcare IT: Tarek Sherif, CEO of Medidata (Part 1)

The clinical data domain is going through major changes and is full of opportunities. This discussion delves into the industry with one of its biggest players.

Sramana Mitra: Let’s introduce our audience to you as well as Medidata.

Tarek Sherif: I’m Tarek Sherif. I’m a Co-Founder, the CEO, and Chairman of Medidata Solutions. We’re a New York-based company but global in operations. We’re focused on helping life sciences companies – biotech, large pharma, and medical device companies as well as academic organizations. >>>

Thought Leaders in Healthcare IT: Carol Clayton, Relias (Part 3)

Sramana Mitra: How do you charge your clients?

Carol Clayton: If you are a provider agency and you’re going to buy a performance solution like Relias, we’re going to look at your enrolled population. It’s generally because in those arrangements, the provider is being paid per member per month (PMPM) to manage that.  >>>

Thought Leaders in Healthcare IT: Carol Clayton, Relias (Part 2)

Sramana Mitra: Let’s take a hospital that has these kinds of behaviors. Could you take us through a live customer and what you have been able to do? What kind of numbers are you seeing?

Carol Clayton: I’m going to use a different model. I won’t use a hospital system. I’m going to use a behavioral health system. In the state of Oklahoma, they have implemented a behavioral health home model for their Medicaid beneficiaries. That is for behavioral health agencies to provide directly or coordinate care for persons with behavioral health disorders who also have chronic health conditions. >>>

Thought Leaders in Healthcare IT: Carol Clayton, Relias (Part 1)

Carol explains certain SaaS-enabled BPO opportunities within the value-based healthcare domain.

Sramana Mitra: Let’s start by introducing our audience to yourself as well as to Relias.

Carol Clayton: I’m a psychologist by training. I worked as the translational neuroscientist at Relias. Relias is a healthcare technology company with footprints specifically in the space of using online tools for training and competency development in the healthcare space. They are evolving their tools and solutions to assist healthcare providers and organizations with better use of data. It also links data to learning so that organizations can be data-driven in looking at their performance within their healthcare vertical. >>>

Thought Leaders in Healthcare IT: Raj Agarwal, CEO of Medocity (Part 5)

Sramana Mitra: I’m just trying to understand the trends of this industry. If a technology provider is selling into the pharmaceutical industry in the digital therapeutics use case, how else is a digital therapeutics use case going to pan out commercially?

Raj Agarwal: It’s early in the game. That’s a new trend. There are three trends we see in the pharma. We talked about digital therapeutic. The other is beyond-the-pill solutions. How do you empower patients digitally who are on their drugs to be better supported? That is happening and is quite active. The third one is the clinical trial. How do you support patients in their clinical trials or through virtual trials? There are three different areas within the pharmaceutical industry that we are focused on. >>>

Thought Leaders in Healthcare IT: Raj Agarwal, CEO of Medocity (Part 4)

Sramana Mitra: Let’s switch the discussion to pharmaceuticals and where drugs are now being enhanced by various kinds of digital monitoring or reporting. What are the trends there? It seems like you have penetration in that use case as well.

Raj Agarwal: One big trend on the pharma side is that they are recognizing that they need to be connected to the patient in terms of providing more support digitally. That’s one big trend where we talked about patient support programs. We see more and more companies going for that. Digital therapeutics is a different animal. >>>

Thought Leaders in Healthcare IT: Raj Agarwal, CEO of Medocity (Part 3)

Sramana Mitra: Let me paraphrase my question and see if you can answer them from a trend point of view. On the value-based care side, whether it’s hospitals or physicians, what trends are you seeing in terms of adoption? How aggressive is the adoption of technologies such as yours?

Raj Agarwal: Frankly, it’s the slowest sector of the three. The decision-making takes anywhere from a year to a year and a half, even longer in some cases. The adoption is increasing, especially in tele-health. The next phase is the remote monitoring and condition management. The biggest receptivity is from organizations that are part of the value-based care or in a shared-risk arrangement.

Sramana Mitra: You just said that that is the slowest adopting sector.

Raj Agarwal: These three sectors are different. >>>

Thought Leaders in Healthcare IT: Raj Agarwal, CEO of Medocity (Part 2)

Raj Agarwal: What we have done uniquely is combine all four aspects into one single platform. It’s seamless and integrated to allow multi-party connectivity. You can add family members or caregivers and engage in a meaningful  way. This is targeted more for complex and high-care chronic conditions. At the heart of what we do is early detection and proactive interventions. >>>